UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Abstract B212: N-myc downstream regulated 1 (NDRG1) is regulated by eukaryotic initiation factor 3a (eIF3a) during cellular stress caused by iron depletion

Molecular cancer therapeutics, 2018-01, Vol.17 (1_Supplement), p.B212-B212

2018

Volltextzugriff (PDF)

Inactivation of Arid1a in the endometrium is associated with endometrioid tumorigenesis through transcriptional reprogramming

Nature communications, 2020-06, Vol.11 (1), p.2717-14, Article 2717

2020

Volltextzugriff (PDF)

Therapeutic Inducers of Apoptosis in Ovarian Cancer

Cancers, 2019-11, Vol.11 (11), p.1786

2019

Volltextzugriff (PDF)

Mitochondrial iron trafficking and the integration of iron metabolism between the mitochondrion and cytosol

Proceedings of the National Academy of Sciences - PNAS, 2010-06, Vol.107 (24), p.10775-10782

2010

Volltextzugriff (PDF)

Roles of Deletion of Arid1a, a Tumor Suppressor, in Mouse Ovarian Tumorigenesis

JNCI : Journal of the National Cancer Institute, 2014-07, Vol.106 (7), p.1

2014

Volltextzugriff (PDF)

N-myc downstream regulated 1 (NDRG1) is regulated by eukaryotic initiation factor 3a (eIF3a) during cellular stress caused by iron depletion

PloS one, 2013-02, Vol.8 (2), p.e57273

2013

Volltextzugriff (PDF)

Inhibition of the MYC-Regulated Glutaminase Metabolic Axis Is an Effective Synthetic Lethal Approach for Treating Chemoresistant Ovarian Cancers

Cancer research (Chicago, Ill.), 2020-10, Vol.80 (20), p.4514-4526

2020

Volltextzugriff (PDF)

Mechanisms underlying acquired platinum resistance in high grade serous ovarian cancer - a mini review

Biochimica et biophysica acta. General subjects, 2019-02, Vol.1863 (2), p.371-378

2019

Volltextzugriff (PDF)

Elucidation of the mechanism of mitochondrial iron loading in Friedreich's ataxia by analysis of a mouse mutant

Proceedings of the National Academy of Sciences - PNAS, 2009-09, Vol.106 (38), p.16381-16386

2009

Volltextzugriff (PDF)

Loss of ARID1A in Tumor Cells Renders Selective Vulnerability to Combined Ionizing Radiation and PARP Inhibitor Therapy

Clinical cancer research, 2019-09, Vol.25 (18), p.5584-5594

2019

Volltextzugriff (PDF)

Inactivating ARID1A Tumor Suppressor Enhances TERT Transcription and Maintains Telomere Length in Cancer Cells

The Journal of biological chemistry, 2016-04, Vol.291 (18), p.9690-9699

2016

Volltextzugriff (PDF)

Iron uptake and metabolism in the new millennium

Trends in cell biology, 2007-02, Vol.17 (2), p.93-100

2007

Volltextzugriff (PDF)

Identification of nonferritin mitochondrial iron deposits in a mouse model of Friedreich ataxia

Proceedings of the National Academy of Sciences - PNAS, 2012-12, Vol.109 (50), p.20590-20595

2012

Volltextzugriff (PDF)

Siderocalin/Lcn2/NGAL/24p3 does not drive apoptosis through gentisic acid mediated iron withdrawal in hematopoietic cell lines

PloS one, 2012-08, Vol.7 (8), p.e43696-e43696

2012

Volltextzugriff (PDF)

Drug repositioning of mevalonate pathway inhibitors as antitumor agents for ovarian cancer

Oncotarget, 2017-09, Vol.8 (42), p.72147-72156

2017

Volltextzugriff (PDF)

MCK mouse heart model of Friedreich's ataxia: Alterations in iron-regulated proteins and cardiac hypertrophy are limited by iron chelation

Proceedings of the National Academy of Sciences - PNAS, 2008-07, Vol.105 (28), p.9757-9762

2008

Volltextzugriff (PDF)

Iron chelator-mediated alterations in gene expression: identification of novel iron-regulated molecules that are molecular targets of hypoxia-inducible factor-1 alpha and p53

Molecular pharmacology, 2010-03, Vol.77 (3), p.443-458

2010

Volltextzugriff (PDF)

The translational regulator eIF3a: The tricky eIF3 subunit

Biochimica et biophysica acta, 2010-12, Vol.1806 (2), p.275-286

2010

Volltextzugriff (PDF)

Coupling of the polyamine and iron metabolism pathways in the regulation of proliferation: Mechanistic links to alterations in key polyamine biosynthetic and catabolic enzymes

Biochimica et biophysica acta. Molecular basis of disease, 2018-09, Vol.1864 (9), p.2793-2813

2018

Volltextzugriff (PDF)

Hepcidin Bound to α2-Macroglobulin Reduces Ferroportin-1 Expression and Enhances Its Activity at Reducing Serum Iron Levels

The Journal of biological chemistry, 2013-08, Vol.288 (35), p.25450-25465

2013

Volltextzugriff (PDF)

Inhibition of ovarian tumor cell invasiveness by targeting SYK in the tyrosine kinase signaling pathway

Oncogene, 2018-07, Vol.37 (28), p.3778-3789

2018

Volltextzugriff (PDF)

The potent and novel thiosemicarbazone chelators di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone and 2-benzoylpyridine-4,4-dimethyl-3-thiosemicarbazone affect crucial thiol systems required for ribonucleotide reductase activity

Molecular pharmacology, 2011-06, Vol.79 (6), p.921-931

2011

Volltextzugriff (PDF)

The medicinal chemistry of novel iron chelators for the treatment of cancer

Current topics in medicinal chemistry, 2011-03, Vol.11 (5), p.483-499

2011

Volltextzugriff (PDF)

TET1 reprograms the epithelial ovarian cancer epigenome and reveals casein kinase 2α as a therapeutic target

The Journal of pathology, 2019-07, Vol.248 (3), p.363-376

2019

Volltextzugriff (PDF)

The ins and outs of mitochondrial iron-loading: the metabolic defect in Friedreich’s ataxia

Journal of molecular medicine (Berlin, Germany), 2010-04, Vol.88 (4), p.323-329

2010

Volltextzugriff (PDF)

1 – 25 von 55

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(52)
Mit Volltextzugriff
(51)

Publikationsform

Artikel
(55)

Sprache

Englisch
(55)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Abstract B212: N-myc downstream regulated 1 (NDRG1) is regulated by eukaryotic initiation factor 3a (eIF3a) during cellular stress caused by iron depletion

Inactivation of Arid1a in the endometrium is associated with endometrioid tumorigenesis through transcriptional reprogramming

Therapeutic Inducers of Apoptosis in Ovarian Cancer

Mitochondrial iron trafficking and the integration of iron metabolism between the mitochondrion and cytosol

Roles of Deletion of Arid1a, a Tumor Suppressor, in Mouse Ovarian Tumorigenesis

N-myc downstream regulated 1 (NDRG1) is regulated by eukaryotic initiation factor 3a (eIF3a) during cellular stress caused by iron depletion

Inhibition of the MYC-Regulated Glutaminase Metabolic Axis Is an Effective Synthetic Lethal Approach for Treating Chemoresistant Ovarian Cancers

Mechanisms underlying acquired platinum resistance in high grade serous ovarian cancer - a mini review

Elucidation of the mechanism of mitochondrial iron loading in Friedreich's ataxia by analysis of a mouse mutant

Loss of ARID1A in Tumor Cells Renders Selective Vulnerability to Combined Ionizing Radiation and PARP Inhibitor Therapy

Inactivating ARID1A Tumor Suppressor Enhances TERT Transcription and Maintains Telomere Length in Cancer Cells

Iron uptake and metabolism in the new millennium

Identification of nonferritin mitochondrial iron deposits in a mouse model of Friedreich ataxia

Siderocalin/Lcn2/NGAL/24p3 does not drive apoptosis through gentisic acid mediated iron withdrawal in hematopoietic cell lines

Drug repositioning of mevalonate pathway inhibitors as antitumor agents for ovarian cancer

MCK mouse heart model of Friedreich's ataxia: Alterations in iron-regulated proteins and cardiac hypertrophy are limited by iron chelation

Iron chelator-mediated alterations in gene expression: identification of novel iron-regulated molecules that are molecular targets of hypoxia-inducible factor-1 alpha and p53

The translational regulator eIF3a: The tricky eIF3 subunit

Coupling of the polyamine and iron metabolism pathways in the regulation of proliferation: Mechanistic links to alterations in key polyamine biosynthetic and catabolic enzymes

Hepcidin Bound to α2-Macroglobulin Reduces Ferroportin-1 Expression and Enhances Its Activity at Reducing Serum Iron Levels

Inhibition of ovarian tumor cell invasiveness by targeting SYK in the tyrosine kinase signaling pathway

The potent and novel thiosemicarbazone chelators di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone and 2-benzoylpyridine-4,4-dimethyl-3-thiosemicarbazone affect crucial thiol systems required for ribonucleotide reductase activity

The medicinal chemistry of novel iron chelators for the treatment of cancer

TET1 reprograms the epithelial ovarian cancer epigenome and reveals casein kinase 2α as a therapeutic target

The ins and outs of mitochondrial iron-loading: the metabolic defect in Friedreich’s ataxia

Suchergebnisse filtern